Feature Of The Week 11/10/13: Volumetric In-Vivo Visualization of Upper Urinary Tract Tumors Using Optical Coherence Tomography: A Pilot Study
Optical Coherence Tomography (OCT) has proven a powerful tool for ophthalmologists to make clinical decisions for a wide range of blinding diseases and the there are now ~20 million ophthalmic OCT patient scans per year. Significant progress is also being made in intravascular imaging where OCT is emerging as a tool for both clinical decision making and the understanding of cardiovascular disease and development of new therapeutic tools. OCT also has the potential to impact the understanding, diagnosis, and treatment of some forms of cancer. There are many leading research groups around the world that are making excellent progress in this area. One example recently published by the Academic Medical Center at the University of Amsterdam investigated the use of OCT in the upper urinary tract tumors. Knowledge of tumor stage and grade is paramount for treatment decisions in cases of upper urinary tract urothelial carcinoma but this condition cannot be accurately assessed by current techniques according to the authors. Optical coherence tomography can hypothetically provide the urologist with real-time intraoperative information on tumor grade and stage. The authors report what to their knowledge are the first results of optical coherence tomography for grading and staging upper urinary tract urothelial carcinoma.
For more information see recent Article. Courtesy of Mieke T. J. Bus from Academic Medical Center at the University of Amsterdam.